Australia
· Delayed Price · Currency is AUD Vitrafy Life Sciences Statistics
Total Valuation
ASX:VFY has a market cap or net worth of AUD 83.64 million. The enterprise value is 49.63 million.
| Market Cap | 83.64M |
| Enterprise Value | 49.63M |
Important Dates
The next estimated earnings date is Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:VFY has 63.85 million shares outstanding. The number of shares has increased by 398.59% in one year.
| Current Share Class | 63.85M |
| Shares Outstanding | 63.85M |
| Shares Change (YoY) | +398.59% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.81% |
| Owned by Institutions (%) | 0.95% |
| Float | 34.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -194.43 |
| PB Ratio | 2.41 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.62 |
Financial Position
The company has a current ratio of 39.71, with a Debt / Equity ratio of 0.01.
| Current Ratio | 39.71 |
| Quick Ratio | 39.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -1.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -35.48% |
| Revenue Per Employee | -19,554 |
| Profits Per Employee | -1.64M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.99 |
| Average Volume (20 Days) | 25,355 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:VFY had revenue of AUD -430,189 and -36.06 million in losses. Loss per share was -2.47.
| Revenue | -430,189 |
| Gross Profit | -521,574 |
| Operating Income | -12.45M |
| Pretax Income | -36.06M |
| Net Income | -36.06M |
| EBITDA | -12.36M |
| EBIT | -12.45M |
| Loss Per Share | -2.47 |
Balance Sheet
The company has 34.45 million in cash and 434,583 in debt, giving a net cash position of 34.02 million or 0.53 per share.
| Cash & Cash Equivalents | 34.45M |
| Total Debt | 434,583 |
| Net Cash | 34.02M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | 34.71M |
| Book Value Per Share | 0.54 |
| Working Capital | 34.42M |
Cash Flow
In the last 12 months, operating cash flow was -6.50 million and capital expenditures -5,307, giving a free cash flow of -6.51 million.
| Operating Cash Flow | -6.50M |
| Capital Expenditures | -5,307 |
| Free Cash Flow | -6.51M |
| FCF Per Share | -0.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | 2,894.60% |
| Pretax Margin | 8,382.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:VFY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -398.59% |
| Shareholder Yield | n/a |
| Earnings Yield | -43.11% |
| FCF Yield | -7.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:VFY has an Altman Z-Score of 52.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 52.15 |
| Piotroski F-Score | 3 |